Total Payments
$1,307
2024 Payments
$1,307
Companies
9
Transactions
53
Payment Breakdown by Category
Food & Beverage$1,307 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,307 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $821.84 | 37 | $0 (2024) |
| UCB, Inc. | $113.22 | 1 | $0 (2024) |
| Incyte Corporation | $106.37 | 4 | $0 (2024) |
| Lilly USA, LLC | $89.67 | 4 | $0 (2024) |
| Amgen Inc. | $59.78 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $37.06 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $31.90 | 1 | $0 (2024) |
| GENZYME CORPORATION | $25.75 | 1 | $0 (2024) |
| Galderma Laboratories, L.P. | $21.46 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,307 | 53 | ABBVIE INC. ($821.84) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $31.90 | General |
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.63 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.48 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.10 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $33.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: Immunology | ||||||
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.87 | General |
| Category: Dermatology | ||||||
About Maria Vanadia, PA-C
Maria Vanadia, PA-C is a Medical healthcare provider based in North Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2024. The National Provider Identifier (NPI) number assigned to this provider is 1861247603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maria Vanadia, PA-C has received a total of $1,307 in payments from pharmaceutical and medical device companies, with $1,307 received in 2024. These payments were reported across 53 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,307).
Ad
Practice Information
- Specialty Medical
- Location North Providence, RI
- Active Since 04/23/2024
- Last Updated 04/23/2024
- Taxonomy Code 363AM0700X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861247603
Products in Payments
- SKYRIZI (Biological) $427.13
- RINVOQ (Biological) $394.71
- Bimzelx (Biological) $113.22
- OPZELURA (Drug) $106.37
- TALTZ (Drug) $89.67
- Otezla (Drug) $59.78
- Sotyktu (Drug) $37.06
- DUPIXENT (Biological) $25.75
- ORACEA (Drug) $21.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.